Basal demographics characteristics and clinical parameters of study groups
AMX+MET | Clindamycin | P value | |
Sex, F/M (%)* | 10/11 (48/53) | 14/7 (67/33) | 0.212 |
Age, years | 52.5 (8.0) | 52.0 (10.6) | 0.950 |
FPG, mg/dL | 134.1 (23.3) | 136.3 (25.7) | 0.950 |
HbA1C, % | 7.1 (0.4) | 7.3 (0.4) | 0.120 |
Tooth, n | 25 (3) | 24 (5) | 0.650 |
Sites, n | 147 (25) | 144 (29) | 0.705 |
Probing depth, mm | 2.4 (0.6) | 2.6 (0.6) | 0.180 |
Plaque index, (%)* | 40.4 (22.9) | 40.7 (21.9) | 0.850 |
Bleeding on probing (%)* | 42.4 (24.2) | 55.6 (25.8) | 0.070 |
P≤0.05.
*Pearson χ2 test. U-Mann-Whitney test.
†Values in mean (SD).
AMX+MET, amoxicillin with metronidazole; F, female; FPG, fasting plasma glucose; M, male.